Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer - An Indian exploratory analysis study

Background: Regorafenib is considered a standard of care as third-line therapy in metastatic colorectal cancers (mCRCs). Materials and Methods: The study was based on a computerized clinical data form sent to oncologists across the country for entry of anonymized patient data. The data entry form w...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Anant Ramaswamy, Vikas Ostwal, Nikhil Pande, Atul Sharma, Shekar Patil, Ravi Thippeswamy, Nikhil Ghadyalpatil, Rakesh Roy, Harish Peshwe, Bhavesh Poladia, Deepan Rajamanickam, Bharat Rangarajan, P R Neelesh Reddy, Vimal Pandita, Ashis Mukherjee, Aniket Thoke, Abhijit Sarkar, C T Satish, H Shashidara, S D Banavali
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2019-01-01
Cyfres:	South Asian Journal of Cancer
Pynciau:	Colorectal cancer India REgorafenib in metastatic colorectal cancer - An Indian eXploratory analysis study regorafenib
Mynediad Ar-lein:	http://journal.sajc.org/article.asp?issn=2278-330X;year=2019;volume=8;issue=1;spage=22;epage=26;aulast=Ramaswamy
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!